fbpx

Tag: New England Journal of Medicine

RIO DE JANEIRO, BRAZIL - The protection provided by Moderna Laboratories' vaccine against the coronavirus lasts at least six months, according to research published Tuesday in the New England Journal of Medicine. The articles echoes what drugmaker Pfizer said...
RIO DE JANEIRO, BRAZIL - The Covid-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal...
RIO DE JANEIRO, BRAZIL - A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective...
RIO DE JANEIRO, BRAZIL - The vaccine against Covid-19 developed by Moderna in partnership with NIH has an overall efficacy of 94.1%, according to a study published on Wednesday, December 30th, in the New England Journal of Medicine. The...

LATEST NEWS

WEATHER

Rio de Janeiro
overcast clouds
19.4 ° C
19.4 °
19.4 °
75 %
0.4kmh
100 %
Mon
22 °
Tue
22 °
Wed
22 °
Thu
22 °
Fri
23 °
error: Content is protected !!